by Joris Van Arensbergen | Dec 4, 2025 | Blog, News, SURE Technology
Annogen is excited to confirm our attendance at the upcoming Advanced Therapies Congress, scheduled for March 17th – 18th, 2026, at ExCeL London! We invite you to schedule a meeting to learn more about how Annogen can support your research and development efforts. Our...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Annogen is thrilled to announce our participation in the upcoming European Society of Gene and Cell Therapy (ESGCT) conference, taking place from October 7th to 10th in beautiful Seville, Spain! As a leading force in advanced therapy innovation, we are eager to...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Barcelona, The Netherlands – September 10, 2025 Lentitek and Annogen join forces to improve the quality and safety of T-cell therapies. This collaboration, jointly announced at the CGTI Leadership Summit today, aims to improve lentivirus-based CAR-T therapies by...
by Joris Van Arensbergen | Sep 10, 2025 | Blog, News, SURE Technology
Our Chief Strategy Officer Martijn Kelder will be speaking at the Cell and Gene Therapy Innovation Leadership Summit in Barcelona, next Thursday at 15:15. His presentation will reveal Annogen’s latest developments in promoter discovery and characterization, revealing...
by admin | Dec 12, 2024 | News, SURE Technology
UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters Annogen, a leader in gene expression engineering, and the prestigious labs of Qizhi Tang and Brian Shy at University of California, San Francisco (UCSF) today announced a collaboration...
